The Effect of Toripalimab Plus Radiotherapy in Patients With Operable Stage II-IIIA (N+) Non Small Cell Lung Cancer

NCT05798845 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

124

Enrollment

OTHER

Sponsor class

Conditions

NSCLC

Interventions

RADIATION: SBRT+LDRT
DRUG: Toripalimab
DRUG: Chemotherapy drug
DRUG: Toripalimab

Sponsor

Shanghai Chest Hospital

Collaborators

[object Object]